See Ling Loy1, Daniel Wei Keong Chan2, Chee Wai Ku3, Yin Bun Cheung4, Keith M Godfrey5, Karen Mei Ling Tan6, Yap-Seng Chong7, Lynette Pei-Chi Shek8, Kok Hian Tan9, Shiao-Yng Chan10, Jerry Kok Yen Chan11, Fabian Yap12. 1. Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore. Electronic address: loyseeling@duke-nus.edu.sg. 2. Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore. 3. Duke-NUS Medical School, Singapore, Singapore; Department of Obstetrics & Gynecology, KK Women's and Children's Hospital, Singapore, Singapore. 4. Program in Health Services & Systems Research and Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore; Tampere Centre for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland. 5. Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, Southampton, United Kingdom. 6. Duke-NUS Medical School, Singapore, Singapore. 7. Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore, Singapore. 8. Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore, Singapore; Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore. 9. Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore. 10. Department of Obstetrics & Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore, Singapore. 11. Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore. 12. Duke-NUS Medical School, Singapore, Singapore; Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Abstract
BACKGROUND: Obesity compromises metabolic health and female fertility, yet not all obese women are similar in metabolic status. The extent to which fecundability is influenced by the metabolic health status of women who are overweight or obese before conception is unknown. OBJECTIVE: This study aimed to: (1) determine the metabolic health status, and (2) examine the association between metabolic health status and fecundability of overweight and obese women trying to conceive in the Singapore PREconception Study of long-Term maternal and child Outcomes cohort study. STUDY DESIGN: We conducted a prospective preconception cohort study of Asian women (Chinese, Malay, and Indian) aged 18 to 45 years trying to conceive who were treated from 2015 to 2017 in KK Women's and Children's Hospital in Singapore (n=834). We defined women to have metabolically unhealthy status if they: (1) met 3 or more modified Joint Interim Statement metabolic syndrome criteria; or (2) had homeostasis model assessment-insulin resistance index ≥2.5. Body mass index was categorized as normal (18.5-22.9 kg/m2), overweight (23-27.4 kg/m2), or obese (≥27.5 kg/m2) on the basis of cutoff points for Asian populations. Fecundability was measured by time to pregnancy in menstrual cycles within a year of enrolment. Discrete-time proportional hazards models were used to estimate fecundability odds ratios, with adjustment for confounders and accounting for left truncation and right censoring. RESULTS: Of 232 overweight women, 28 (12.1%) and 25 (10.8%) were metabolically unhealthy by metabolic syndrome ≥3 criteria and homeostasis model assessment-insulin resistance ≥2.5, respectively. Of 175 obese women, 54 (30.9%) and 93 (53.1%) were metabolically unhealthy by metabolic syndrome ≥3 criteria and homeostasis model assessment-insulin resistance ≥2.5, respectively. Compared with metabolically healthy normal-weight women, lower fecundability was observed in metabolically unhealthy overweight women on the basis of metabolic syndrome criteria (fecundability odds ratios, 0.38 [95% confidence interval, 0.15-0.92]) and homeostasis model assessment-insulin resistance (fecundability odds ratios, 0.68 [95% confidence interval, 0.33-1.39]), with metabolic syndrome criteria showing a stronger association. Metabolically unhealthy obese women showed lower fecundability than the healthy normal-weight reference group by both metabolic syndrome (fecundability odds ratios, 0.35; 95% confidence interval, 0.17-0.72) and homeostasis model assessment-insulin resistance criteria (fecundability odds ratios, 0.43; 95% confidence interval, 0.26-0.71). Reduced fecundability was not observed in overweight or obese women who showed healthy metabolic profiles by either definition. CONCLUSION: Overweight or obesity was not synonymous with having metabolic syndrome or insulin resistance. In our preconception cohort, metabolically unhealthy overweight and obese women showed reduced fecundability, unlike their counterparts who were metabolically healthy. These findings suggest that metabolic health status, rather than simply being overweight and obese per se, plays an important role in fecundability.
BACKGROUND: Obesity compromises metabolic health and female fertility, yet not all obese women are similar in metabolic status. The extent to which fecundability is influenced by the metabolic health status of women who are overweight or obese before conception is unknown. OBJECTIVE: This study aimed to: (1) determine the metabolic health status, and (2) examine the association between metabolic health status and fecundability of overweight and obese women trying to conceive in the Singapore PREconception Study of long-Term maternal and child Outcomes cohort study. STUDY DESIGN: We conducted a prospective preconception cohort study of Asian women (Chinese, Malay, and Indian) aged 18 to 45 years trying to conceive who were treated from 2015 to 2017 in KK Women's and Children's Hospital in Singapore (n=834). We defined women to have metabolically unhealthy status if they: (1) met 3 or more modified Joint Interim Statement metabolic syndrome criteria; or (2) had homeostasis model assessment-insulin resistance index ≥2.5. Body mass index was categorized as normal (18.5-22.9 kg/m2), overweight (23-27.4 kg/m2), or obese (≥27.5 kg/m2) on the basis of cutoff points for Asian populations. Fecundability was measured by time to pregnancy in menstrual cycles within a year of enrolment. Discrete-time proportional hazards models were used to estimate fecundability odds ratios, with adjustment for confounders and accounting for left truncation and right censoring. RESULTS: Of 232 overweight women, 28 (12.1%) and 25 (10.8%) were metabolically unhealthy by metabolic syndrome ≥3 criteria and homeostasis model assessment-insulin resistance ≥2.5, respectively. Of 175 obese women, 54 (30.9%) and 93 (53.1%) were metabolically unhealthy by metabolic syndrome ≥3 criteria and homeostasis model assessment-insulin resistance ≥2.5, respectively. Compared with metabolically healthy normal-weight women, lower fecundability was observed in metabolically unhealthy overweight women on the basis of metabolic syndrome criteria (fecundability odds ratios, 0.38 [95% confidence interval, 0.15-0.92]) and homeostasis model assessment-insulin resistance (fecundability odds ratios, 0.68 [95% confidence interval, 0.33-1.39]), with metabolic syndrome criteria showing a stronger association. Metabolically unhealthy obese women showed lower fecundability than the healthy normal-weight reference group by both metabolic syndrome (fecundability odds ratios, 0.35; 95% confidence interval, 0.17-0.72) and homeostasis model assessment-insulin resistance criteria (fecundability odds ratios, 0.43; 95% confidence interval, 0.26-0.71). Reduced fecundability was not observed in overweight or obese women who showed healthy metabolic profiles by either definition. CONCLUSION: Overweight or obesity was not synonymous with having metabolic syndrome or insulin resistance. In our preconception cohort, metabolically unhealthy overweight and obese women showed reduced fecundability, unlike their counterparts who were metabolically healthy. These findings suggest that metabolic health status, rather than simply being overweight and obese per se, plays an important role in fecundability.
Authors: Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Enrique F Schisterman; Sunni L Mumford; Richard W Browne; Dana Boyd Barr; Zhen Chen; Germaine M Buck Louis Journal: J Clin Endocrinol Metab Date: 2014-05-20 Impact factor: 5.958
Authors: Maria C Magnus; Abigail Fraser; Janet W Rich-Edwards; Per Magnus; Deborah A Lawlor; Siri E Håberg Journal: Eur J Epidemiol Date: 2021-01-25 Impact factor: 12.434
Authors: Shu-E Soh; See Ling Loy; Evelyn Xiu Ling Loo; Sharon Ng; Mya Thway Tint; Shiao-Yng Chan; Jonathan Yinhao Huang; Fabian Yap; Kok Hian Tan; Bernard S M Chern; Heng Hao Tan; Michael J Meaney; Neerja Karnani; Keith M Godfrey; Yung Seng Lee; Jerry Kok Yen Chan; Peter D Gluckman; Yap-Seng Chong; Lynette Pei-Chi Shek; Johan G Eriksson; Airu Chia; Anna Magdalena Fogel; Anne Eng Neo Goh; Anne Hin Yee Chu; Anne Rifkin-Graboi; Anqi Qiu; Bee Wah Lee; Bobby Kyungbeom Cheon; Candida Vaz; Christiani Jeyakumar Henry; Ciaran Gerard Forde; Claudia Chi; Dawn Xin Ping Koh; Desiree Y Phua; Doris Ngiuk Lan Loh; Elaine Phaik Ling Quah; Elizabeth Huiwen Tham; Evelyn Chung Ning Law; Faidon Magkos; Falk Mueller-Riemenschneider; George Seow Heong Yeo; Hannah Ee Juen Yong; Helen Yu Chen; Heng Hao Tan; Hong Pan; Hugo P S van Bever; Hui Min Tan; Izzuddin Bin Mohd Aris; Jeannie Tay; Jerry Kok Yen Chan; Jia Xu; Joanne Su-Yin Yoong; Johan Gunnar Eriksson; Jonathan Tze Liang Choo; Jonathan Y Bernard; Jonathan Yinhao Huang; Jun Shi Lai; Karen Mei Ling Tan; Keith M Godfrey; Kenneth Yung Chiang Kwek; Keri McCrickerd; Kothandaraman Narasimhan; Kok Wee Chong; Kuan Jin Lee; Li Chen; Lieng Hsi Ling; Ling-Wei Chen; Lourdes Mary Daniel; Lynette Pei-Chi Shek; Marielle V Fortier; Mary Foong-Fong Chong; Mei Chien Chua; Melvin Khee-Shing Leow; Michelle Zhi Ling Kee; Min Gong; Mya Thway Tint; Navin Michael; Ngee Lek; Oon Hoe Teoh; Priti Mishra; Queenie Ling Jun Li; Sambasivam Sendhil Velan; Seng Bin Ang; Shirong Cai; Si Hui Goh; Sok Bee Lim; Stella Tsotsi; Stephen Chin-Ying Hsu; Sue-Anne Ee Shiow Toh; Suresh Anand Sadananthan; Teng Hong Tan; Tong Wei Yew; Varsha Gupta; Victor Samuel Rajadurai; Wee Meng Han; Wei Wei Pang; Wen Lun Yuan; Yanan Zhu; Yin Bun Cheung; Yiong Huak Chan; Zai Ru Cheng Journal: Eur J Epidemiol Date: 2020-11-21 Impact factor: 8.082
Authors: Ziyi Zhou; John Macpherson; Stuart R Gray; Jason M R Gill; Paul Welsh; Carlos Celis-Morales; Naveed Sattar; Jill P Pell; Frederick K Ho Journal: Diabetologia Date: 2021-06-10 Impact factor: 10.122